Change Healthcare Inc., an independent healthcare technology platform, provides data and analytics-driven solutions to enhance clinical, financial, administrative, and patient engagement outcomes in the United States healthcare system. More Details
No risks detected for CHNG from our risk checks.
Reasonable growth potential and fair value.
Share Price & News
How has Change Healthcare's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: CHNG is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 10% a week.
Volatility Over Time: CHNG's weekly volatility (10%) has been stable over the past year.
7 Day Return
US Healthcare Services
1 Year Return
US Healthcare Services
Return vs Industry: CHNG underperformed the US Healthcare Services industry which returned 62.2% over the past year.
Return vs Market: CHNG exceeded the US Market which returned 19.6% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Change Healthcare's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 weeks ago | Simply Wall StDid You Miss Change Healthcare's (NASDAQ:CHNG) 16% Share Price Gain?
1 month ago | Simply Wall StChange Healthcare (NASDAQ:CHNG) Has Debt But No Earnings; Should You Worry?
2 months ago | Simply Wall StShould You Take Comfort From Insider Transactions At Change Healthcare Inc. (NASDAQ:CHNG)?
Is Change Healthcare undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: CHNG ($24) is trading below our estimate of fair value ($34.67)
Significantly Below Fair Value: CHNG is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: CHNG is unprofitable, so we can't compare its PE Ratio to the US Healthcare Services industry average.
PE vs Market: CHNG is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate CHNG's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: CHNG is good value based on its PB Ratio (2.3x) compared to the US Healthcare Services industry average (6.4x).
How is Change Healthcare forecast to perform in the next 1 to 3 years based on estimates from 17 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CHNG is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%).
Earnings vs Market: CHNG is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: CHNG's is expected to become profitable in the next 3 years.
Revenue vs Market: CHNG's revenue (8.6% per year) is forecast to grow slower than the US market (10.2% per year).
High Growth Revenue: CHNG's revenue (8.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CHNG's Return on Equity is forecast to be very high in 3 years time (152%).
How has Change Healthcare performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CHNG is currently unprofitable.
Growing Profit Margin: CHNG is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: CHNG is unprofitable, and losses have increased over the past 5 years at a rate of 106% per year.
Accelerating Growth: Unable to compare CHNG's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CHNG is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (-29.9%).
Return on Equity
High ROE: CHNG has a negative Return on Equity (-28.59%), as it is currently unprofitable.
How is Change Healthcare's financial position?
Financial Position Analysis
Short Term Liabilities: CHNG's short term assets ($1.1B) exceed its short term liabilities ($893.6M).
Long Term Liabilities: CHNG's short term assets ($1.1B) do not cover its long term liabilities ($6.1B).
Debt to Equity History and Analysis
Debt Level: CHNG's debt to equity ratio (157.4%) is considered high.
Reducing Debt: Insufficient data to determine if CHNG's debt to equity ratio has reduced over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable CHNG has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: CHNG is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 96.8% per year.
What is Change Healthcare current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate CHNG's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate CHNG's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if CHNG's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if CHNG's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of CHNG's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Neil de Crescenzo (59 yo)
Mr. Neil E. de Crescenzo, IV serves as President and Chief Executive Officer at Change Healthcare, Inc. and has been its Director since June 26, 2019. He has been the Chief Executive Officer and President ...
CEO Compensation Analysis
Compensation vs Market: Neil's total compensation ($USD9.50M) is above average for companies of similar size in the US market ($USD6.20M).
Compensation vs Earnings: Neil's compensation has increased whilst the company is unprofitable.
|President||no data||US$9.50m||0.065% |
|Executive VP & CFO||2.83yrs||US$3.76m||0.056% |
|Executive VP & President of Network Solutions||no data||US$2.24m||0% |
|Executive VP & President of Technology Enabled Services||no data||US$2.22m||0% |
|Executive VP and President of Software & Analytics||no data||US$3.11m||0.00066% |
|Executive VP and President of Sales & Operations||no data||US$2.65m||0.00033% |
|Senior Vice President of Investor Relations||no data||no data||no data|
|Executive VP & General Counsel||no data||no data||no data|
|Chief Compliance & Ethics Officer||0.33yr||no data||no data|
|Vice President of External Communications||no data||no data||no data|
|Executive VP of Corporate Affairs & Chief Marketing Officer||no data||no data||0.00033% |
|Senior Vice President of Corporate Development||1.17yrs||no data||no data|
Experienced Management: CHNG's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.
|President||no data||US$9.50m||0.065% |
|Director||1.58yrs||no data||no data|
|Independent Director||1.58yrs||US$322.08k||0.020% |
|Independent Director||1.58yrs||US$307.08k||0% |
|Independent Chairman||1yr||US$333.33k||0.061% |
|Independent Director||1.58yrs||US$322.08k||0% |
|Independent Director||0.58yr||no data||0.0033% |
|Independent Director||1.42yrs||US$252.08k||no data|
|Independent Director||1.58yrs||no data||no data|
|Independent Director||0.67yr||no data||no data|
Experienced Board: CHNG's board of directors are not considered experienced ( 1.6 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Change Healthcare Inc.'s company bio, employee growth, exchange listings and data sources
- Name: Change Healthcare Inc.
- Ticker: CHNG
- Exchange: NasdaqGS
- Founded: 2016
- Industry: Health Care Technology
- Sector: Healthcare
- Market Cap: US$7.335b
- Shares outstanding: 305.61m
- Website: https://www.changehealthcare.com
Number of Employees
- Change Healthcare Inc.
- 3055 Lebanon Pike
- Suite 1000
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|CHNG||NasdaqGS (Nasdaq Global Select)||Yes||Common Stock||US||USD||Jun 2019|
|1CB||MUN (Boerse Muenchen)||Yes||Common Stock||DE||EUR||Jun 2019|
|CHNG *||BMV (Bolsa Mexicana de Valores)||Yes||Common Stock||MX||MXN||Jun 2019|
Change Healthcare Inc., an independent healthcare technology platform, provides data and analytics-driven solutions to enhance clinical, financial, administrative, and patient engagement outcomes in the Un...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/01/17 00:36|
|End of Day Share Price||2021/01/15 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.